The Booster Vaccine Against Covid Will Be Available In The UK Starting Next Week.

They say the booster should be given at least six months after receiving the second dose - with Pfizer BioNTech's recommended stroke. Eligible are over 50 years of age, young adults with health problems, and first aid in the health and care sector. Health Minister Sajid Javid announced in the House of Commons as part of the UK's Covid fall-winter management plan.

Scotland will begin offering pushback strikes to the broader group on Monday, Prime Minister Nicholas Sturgeon said. He said the program "aims to expand vaccine protection" and work closely with the flu vaccination program. Consent has also been confirmed in Wales and Northern Ireland. Rare death from COVID among fully vaccinated people - ONS

Pfizer and AZ are used as booster vaccines against Covid.

The recommendations from the JCVI (Joint Committee on Vaccination and Vaccination) come against the backdrop of concerns about weakening immunity. There is some evidence that the protection offered by the vaccine may wear off several months after the second dose - with the most vulnerable groups being the most at risk.

JCVI said it was not yet clear exactly how much protection was slipping but wanted to take a precautionary approach and ensure that those most at risk maintain a high level of security. The advice is separate from the recent third dose recommendation for people with severely weakened immune systems, which is already being implemented.

Those eligible for hit boosters include:

There is significant uncertainty about what winter will bring. It is not clear what will happen next month. It is feared that Covid cases could increase in September, but there is still no sign that this will happen.

The big jump in infection numbers may be behind us, given how much population has built up immunity. But if current levels are maintained over the winter, the NHS will struggle. And even a tiny drop in vaccine effectiveness can significantly impact approval - hence the announcement of booster vaccinations.

Then there are concerns about the return of another respiratory virus. They were marginalized last year because of the blockade and social distancing, but that means their immunity has weakened.

Therefore, the NHS needs to prepare for the worst while hoping for the best. JCVI showed that Pfizer was well tolerated and evoked a good immune response, even against new virus variants such as Delta, regardless of which Covid vaccine was given for the first two doses.